← Back to Search

Behavioral Intervention

SISTA-P Intervention for Health Literacy (SISTA-P Trial)

N/A

Recruiting

Led By Shawnika Hull, PhD

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at the end of each cycle (each cycle is 42 days)

Awards & highlights

SISTA-P Trial Summary

"This trial aims to provide specialized HIV prevention training and empowerment sessions to Black women in Washington D.C. who are at high risk for contracting HIV. The goal is to lower the rates of HIV transmission within

Who is the study for?

This trial is specifically for Black women aged 18 or older who are sexually active with men, live in Washington D.C., and do not have HIV. It aims to empower them with HIV prevention training tailored to their experiences.Check my eligibility

What is being tested?

The SISTA-P Intervention is being tested, which involves new HIV prevention training and empowerment sessions designed for the unique challenges faced by Black women in reducing HIV transmission rates within their community.See study design

What are the potential side effects?

Since this intervention focuses on education and empowerment without medical treatments, there are no direct physical side effects. However, participants may experience emotional or psychological impacts from discussing sensitive topics.

SISTA-P Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at the end of each cycle (each cycle is 42 days)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at the end of each cycle (each cycle is 42 days)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at the end of each cycle (each cycle is 42 days) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of the Intervention Scale

Appropriateness of the Intervention Scale

Feasibility of the Intervention Scale

Secondary outcome measures

Acceptability of the intervention delivery

Feasibility of delivering 6 sessions in 6 weeks

Intervention Fidelity

+6 more

SISTA-P Trial Design

1Treatment groups

Experimental Treatment

Group I: SISTA-P InterventionExperimental Treatment1 Intervention

Participants will complete four sessions lasting up to three hours each over the course of one week. The sessions will be overseen by two facilitators and a technical monitor. Core elements of SISTA-P are: (1) small group discussions, modeling and role-play that facilitate repetition, reinforcement and sequential approximation; (2) skilled facilitators; (3) gender and culturally specific materials to enhance pride and self-worth; (4) teaching negotiation, self-advocacy; and (5) HIV prevention relevant skills; (6) discussing gender and culture-specific barriers and facilitators to prevention; and (7) enhancing HIV prevention norms and self-efficacy. Each discussion group will consist of 12- 15 participants and each cycle will consist of one group. Participants will be asked to complete a follow up survey and two booster sessions. They will also be asked to submit photo-confirmation of PrEP prescription to the research team.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor

429 Previous Clinical Trials

64,202 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,701 Previous Clinical Trials

7,506,820 Total Patients Enrolled

2 Trials studying Health Literacy

1,057 Patients Enrolled for Health Literacy

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,619,701 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are potential candidates still eligible to participate in this ongoing clinical trial?

"As per the details on clinicaltrials.gov, this study is currently in search of eligible participants. Its initial posting date was January 8th, 2024, and its latest revision occurred on March 6th, 2024."

Answered by AI

What is the total number of participants being recruited for this clinical study?

"Indeed, as per the details on clinicaltrials.gov, this ongoing study is actively seeking suitable candidates. The trial was initially listed on 1/8/2024 and last revised on 3/6/2024. A total of 30 participants are sought from two distinct locations."

Answered by AI

What is the primary objective of this medical study?

"The primary goal of this investigation, evaluated every 42 days at the conclusion of each cycle, is to gauge the Acceptability of the Intervention Scale. Secondary aims encompass Post-Intervention Follow-up, quantified by the percentage of post-intervention surveys submitted achieving a benchmark rate of 80%, Visual confirmation validating self-reported Prep uptake through photo evidence, and assessing Feasibility in administering six sessions within a span on six weeks as outlined in the study timeline."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P)

Shawnika J. Hull, PhD 2024. "Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06307028.

All > Paid Studies Baltimore > Aids